Literature DB >> 25100515

Group seeks standardization for what clinical trials must measure.

Amanda B Keener.   

Abstract

Mesh：

Year:  2014        PMID： 25100515     DOI： 10.1038/nm0814-798

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes.

Authors:  T Sanderson; M Morris; M Calnan; P Richards; S Hewlett
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 2.  Choosing important health outcomes for comparative effectiveness research: a systematic review.

Authors:  Elizabeth Gargon; Binu Gurung; Nancy Medley; Doug G Altman; Jane M Blazeby; Mike Clarke; Paula R Williamson
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240
  2 in total
  2 in total

1.  Assessing the relative efficacy of new drugs: an emerging opportunity.

Authors:  Hans-Georg Eichler; Andrew Thomson; Irmgard Eichler; Sebastian Schneeweiss
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

2.  The COMET initiative database: progress and activities update (2014).

Authors:  Elizabeth Gargon; Paula R Williamson; Doug G Altman; Jane M Blazeby; Mike Clarke
Journal:  Trials       Date:  2015-11-11       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.